Cisplatin induces stemness in ovarian cancer

The mainstay of treatment for ovarian cancer is platinum-based cytotoxic chemotherapy. However, therapeutic resistance and recurrence is a common eventuality for nearly all ovarian cancer patients, resulting in poor median survival. Recurrence is postulated to be driven by a population of self-renew...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiechert, Andrew, Saygin, Caner, Thiagarajan, Praveena S., Rao, Vinay S., Hale, James S., Gupta, Nikhil, Hitomi, Masahiro, Nagaraj, Anil Belur, DiFeo, Analisa, Lathia, Justin D., Reizes, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058697/
https://www.ncbi.nlm.nih.gov/pubmed/27105520
http://dx.doi.org/10.18632/oncotarget.8852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058697/
https://www.ncbi.nlm.nih.gov/pubmed/27105520
http://dx.doi.org/10.18632/oncotarget.8852

Ejemplares similares